PHARMACEUTICAL ECONSULTING A/S
CVR 30815378Public limited company (A/S)Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (749990)GlostrupFounded 3 Sep 2007
Employees
9
CVR registry, Jul 2026
0 (0%) over 12 months
Gross profit
6,1M
DKK, annual report 2025
+10,4% on 2024
Result
-1,1M
DKK, annual report 2025
Equity
5,2M
DKK, annual report 2025
Who Is Behind It
- Owner
RUGAARD HOLDING ApSCVR 30815351, 100% of capital and votes, since 3 Sep 2007
- Ultimate controller
- Steen Otto Rugaardthrough RUGAARD HOLDING ApS, a Dandex estimate, owner-managed
- Director
Steen Otto Rugaardsince 14 Jun 2016
Ownership
- RUGAARD HOLDING ApS
CVR 30815351100% of capital and votessince 3 Sep 2007
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
Control Chain
Ultimate controller
Holds 100% of capital and votes in RUGAARD HOLDING ApS, since 3 Sep 2007
Capital100%Votes100%Holding company
CVR 30815351Private limited company (ApS)
Holds 100% of capital and votes in PHARMACEUTICAL ECONSULTING A/S, since 3 Sep 2007
Capital100%Votes100%This company
PHARMACEUTICAL ECONSULTING A/S
CVR 30815378
People
Current (3)
- Steen Otto RugaardExecutive board since 14 Jun 2016, Board of directors since 14 Jun 2016
- Hanne Laurberg OlesenBoard of directors since 14 Jun 2016
- Pernille Laurberg RugaardBoard of directors since 14 Jun 2016
Founders (1)
- RUGAARD HOLDING ApSFounded 3 Sep 2007, holds a current role
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Former (1)
- Jens Christian Pii OlesenBoard of directors 1 Oct 2007 to 31 Dec 2015
Network
Roles Over Time
- Steen Otto Rugaard: Executive board, 14 Jun 2016 to today; Board of directors, 14 Jun 2016 to today; Executive board, 3 Sep 2007 to 6 Apr 2016; Board of directors, 3 Sep 2007 to 6 Apr 2016.
- Hanne Laurberg Olesen: Board of directors, 14 Jun 2016 to today; Board of directors, 3 Sep 2007 to 6 Apr 2016.
- Pernille Laurberg Rugaard: Board of directors, 14 Jun 2016 to today; Board of directors, 1 Oct 2007 to 6 Apr 2016.
3 Sep 2007 to 20 Oct 2026.
Former (1)
Financials
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | 8.276 | 6.779 | 5.579 | 5.538 | 6.114 |
| Operating profit | +3.050 | +770 | -395 | -941 | -1.268 |
| Result for the year | +2.420 | +780 | -384 | -644 | -1.067 |
| Equity | 6.467 | 7.247 | 6.863 | 6.220 | 5.153 |
| Total assets | 19.658 | 8.092 | 7.991 | 8.806 | 10.595 |
| Employees (average) | 5 | 8 | 8 | 8 | 0 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Annual Reports
Annual report 2025
1 Oct 2024 to 30 Sep 2025, published 17 Apr 2026
Annual report 2024
1 Oct 2023 to 30 Sep 2024, published 11 Apr 2025
Annual report 2023
1 Oct 2022 to 30 Sep 2023, published 25 Apr 2024
Annual report 2022
1 Oct 2021 to 30 Sep 2022, published 6 Apr 2023
Annual report 2021
1 Oct 2020 to 30 Sep 2021, published 16 Mar 2022
Changes
All changesRegistration
- Address
- Naverland 2
2600 Glostrup
Albertslund Municipality - CVR record last changed
- 17 Apr 2026
- Data read
- 20 Oct 2026
Production Units
1 registered in CVR.
- PHARMACEUTICAL ECONSULTING A/S
P-number 1013575963Naverland 2, 2600 Glostrup
Source: the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen. Annual reports via XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Ask About PHARMACEUTICAL ECONSULTING A/S With AI
Connect Dandex to Claude, ChatGPT or Cursor to compare years, check credit and map the people around a company.